214 related articles for article (PubMed ID: 34419967)
21. Does evidence support the use of cat allergen immunotherapy?
Dhami S; Agarwal A
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
[TBL] [Abstract][Full Text] [Related]
22. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.
Frischmeyer-Guerrerio PA; Masilamani M; Gu W; Brittain E; Wood R; Kim J; Nadeau K; Jarvinen KM; Grishin A; Lindblad R; Sampson HA
J Allergy Clin Immunol; 2017 Oct; 140(4):1043-1053.e8. PubMed ID: 28414061
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
Ridolo E; Pellicelli I; Kihlgren P; Nizi MC; Pucciarini F; Senna G; Incorvaia C
Expert Opin Biol Ther; 2019 Sep; 19(9):919-925. PubMed ID: 31190572
[No Abstract] [Full Text] [Related]
24. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
Virkud YV; Wang J; Shreffler WG
Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
[TBL] [Abstract][Full Text] [Related]
25. Omalizumab in children with severe allergic disease: a case series.
Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
[TBL] [Abstract][Full Text] [Related]
26. What you should not miss from the systematic reviews and meta-analyses on allergen-specific immunotherapy in 2017.
Larenas-Linnemann D; Luna-Pech JA
Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):168-176. PubMed ID: 29629956
[TBL] [Abstract][Full Text] [Related]
27. Omalizumab facilitates rapid oral desensitization for peanut allergy.
MacGinnitie AJ; Rachid R; Gragg H; Little SV; Lakin P; Cianferoni A; Heimall J; Makhija M; Robison R; Chinthrajah RS; Lee J; Lebovidge J; Dominguez T; Rooney C; Lewis MO; Koss J; Burke-Roberts E; Chin K; Logvinenko T; Pongracic JA; Umetsu DT; Spergel J; Nadeau KC; Schneider LC
J Allergy Clin Immunol; 2017 Mar; 139(3):873-881.e8. PubMed ID: 27609658
[TBL] [Abstract][Full Text] [Related]
28. Oral Immunotherapy for Food Allergy.
Wood RA
J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
[TBL] [Abstract][Full Text] [Related]
29. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
[TBL] [Abstract][Full Text] [Related]
30. Allergen immunotherapy: an update on protocols of administration.
Larenas-Linnemann D
Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):556-67. PubMed ID: 26485100
[TBL] [Abstract][Full Text] [Related]
31. [Safety comparison of omalizumab and glucocorticoid in rush allergen immunotherapy].
Gao P; Yu W; Zhou Y; Zhu W; Zhu Z; Jiang Y; Cheng Q; Wang Y; Kong W; Zhu X; Qiu Q; Chen J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jul; 34(7):610-614. PubMed ID: 32791635
[No Abstract] [Full Text] [Related]
32. Omalizumab and hypersensitivity reactions.
Shankar T; Petrov AA
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):19-24. PubMed ID: 23242113
[TBL] [Abstract][Full Text] [Related]
33. How to actively treat food allergy.
Pecora V; Mennini M; Calandrelli V; Patriarca G; Valluzzi R; Fierro V
Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):248-257. PubMed ID: 29629957
[TBL] [Abstract][Full Text] [Related]
34. New developments in the diagnosis and treatment of hymenoptera venom allergy.
Müller UR
Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
[TBL] [Abstract][Full Text] [Related]
35. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.
Klunker S; Saggar LR; Seyfert-Margolis V; Asare AL; Casale TB; Durham SR; Francis JN;
J Allergy Clin Immunol; 2007 Sep; 120(3):688-95. PubMed ID: 17631952
[TBL] [Abstract][Full Text] [Related]
36. Biologicals in IgE-mediated food allergy.
Mutarelli A; Giavina-Bianchi B; Arasi S; Cafarotti A; Fiocchi A
Curr Opin Allergy Clin Immunol; 2023 Jun; 23(3):205-209. PubMed ID: 37185824
[TBL] [Abstract][Full Text] [Related]
37. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
Scurlock AM
Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy in food allergy: towards new strategies.
Sato S; Yanagida N; Ogura K; Asaumi T; Okada Y; Koike Y; Iikura K; Syukuya A; Ebisawa M
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):195-202. PubMed ID: 25268336
[TBL] [Abstract][Full Text] [Related]
39. Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents.
Brandström J; Vetander M; Sundqvist AC; Lilja G; Johansson SGO; Melén E; Sverremark-Ekström E; Nopp A; Nilsson C
Clin Exp Allergy; 2019 Oct; 49(10):1328-1341. PubMed ID: 31329313
[TBL] [Abstract][Full Text] [Related]
40. Clinical aspects of oral immunotherapy for the treatment of allergies.
Yanagida N; Sato S; Ebisawa M
Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
